• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Illumina, Inc. - Common Stock (NQ:ILMN)

    127.55 -1.17 (-0.91%)
    Streaming Delayed Price Updated: 4:00 PM EST, Dec 2, 2025 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 1,090,491
    Open 129.01
    Bid (Size) 126.70 (300)
    Ask (Size) 133.00 (300)
    Prev. Close 128.72
    Today's Range 127.43 - 129.50
    52wk Range 68.70 - 153.06
    Shares Outstanding 152,800,000
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    popEVE AI: Harvard-Developed Model Set to Revolutionize Rare Disease Diagnosis and Drug Discovery
    Cambridge, MA & Barcelona, Spain – November 25, 2025 – A groundbreaking artificial intelligence model, popEVE, developed by a collaborative team of researchers from Harvard Medical School and the... 
    Via TokenRing AI
    Topics Artificial Intelligence
    News headline image
    The Ensign Group, Illumina, and Amphastar Pharmaceuticals Shares Skyrocket, What You Need To Know
    A number of stocks jumped in the afternoon session after comments from a key Federal Reserve official bolstered hopes for an interest rate cut. New York Federal Reserve President John Williams stated... 
    Via StockStory
    Topics Economy

    Performance

    YTD
    -2.6%
    -2.6%
    1 Month
    +6.3%
    +6.3%
    3 Month
    +30.4%
    +30.4%
    6 Month
    +57.3%
    +57.3%
    1 Year
    -12.1%
    -12.1%

    More News

    Read More
    News headline image
    Illumina Inc (NASDAQ:ILMN) Presents a Compelling Case for Value Investors ↗
    Via Chartmill
    News headline image
    Earnings Scheduled For October 30, 2025 ↗
    Via Benzinga
    News headline image
    3 Reasons to Sell ILMN and 1 Stock to Buy Instead
    Via StockStory
    News headline image
    3 Unpopular Stocks with Warning Signs
    Via StockStory
    News headline image
    1 Momentum Stock with Promising Prospects and 2 We Avoid
    Via StockStory
    News headline image
    Cisco, Morgan Stanley, FTAI Aviation And A Health Care Stock On CNBC's 'Final Trades' ↗
    Via Benzinga
    News headline image
    Nvidia's AI Reign: A $5 Trillion Bellwether Shaping Wall Street's Fortunes
    Via MarketMinute
    Topics Artificial Intelligence Economy Law Enforcement
    News headline image
    AI’s Next Frontier: Key Stocks to Watch Amidst Market Shifts and Technological Leaps
    Via TokenRing AI
    Topics Artificial Intelligence
    News headline image
    1 Profitable Stock Worth Investigating and 2 Facing Headwinds
    Via StockStory
    News headline image
    5 Revealing Analyst Questions From Illumina’s Q3 Earnings Call
    Via StockStory
    Topics Earnings
    News headline image
    10x Genomics Earnings: What To Look For From TXG
    Via StockStory
    News headline image
    PacBio Earnings: What To Look For From PACB
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Illumina (ILMN) Stock Trades Down, Here Is Why
    Via StockStory
    Topics Artificial Intelligence Supply Chain
    News headline image
    Biotech ETFs Come Alive As Illumina Soars 23% — Is The Genomics Winter Finally Over? ↗
    Via Benzinga
    Topics ETFs
    News headline image
    Teradyne, Wayfair, And Illumina Are Among the Top 10 Large-Cap Gainers Last Week (Oct. 27-Oct. 31): Are the Others in Your Portfolio? ↗
    Via Benzinga
    News headline image
    Dow Falls Over 100 Points; Amazon Posts Upbeat Q3 Results ↗
    Via Benzinga
    Topics Stocks
    News headline image
    12 Health Care Stocks Moving In Friday's Intraday Session ↗
    Via Benzinga
    News headline image
    Why Illumina (ILMN) Stock Is Up Today
    Via StockStory
    Topics Economy Government World Trade
    News headline image
    DNA Sequencing Firm Illumina Sees Strong Clinical Market Momentum, Stock Soars ↗
    Via Benzinga
    News headline image
    Cloudflare Posts Upbeat Q3 Results, Joins Amazon, Roku, Coinbase, Atlassian And Other Big Stocks Moving Higher On Friday ↗
    Via Benzinga
    News headline image
    ILMN Q3 Deep Dive: Clinical Sequencing Momentum and Cost Discipline Drive Outperformance
    Via StockStory
    News headline image
    Illumina Inc (NASDAQ:ILMN) Surpasses Profit Expectations in Q3 2025, Sparking 8.6% Stock Rally ↗
    Via Chartmill
    Topics Earnings
    News headline image
    Illumina (NASDAQ:ILMN) Beats Q3 Sales Expectations
    Via StockStory

    Frequently Asked Questions

    Is Illumina, Inc. - Common Stock publicly traded?
    Yes, Illumina, Inc. - Common Stock is publicly traded.
    What exchange does Illumina, Inc. - Common Stock trade on?
    Illumina, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Illumina, Inc. - Common Stock?
    The ticker symbol for Illumina, Inc. - Common Stock is ILMN on the Nasdaq Stock Market
    What is the current price of Illumina, Inc. - Common Stock?
    The current price of Illumina, Inc. - Common Stock is 127.55
    When was Illumina, Inc. - Common Stock last traded?
    The last trade of Illumina, Inc. - Common Stock was at 12/02/25 04:00 PM ET
    What is the market capitalization of Illumina, Inc. - Common Stock?
    The market capitalization of Illumina, Inc. - Common Stock is 19.49B
    How many shares of Illumina, Inc. - Common Stock are outstanding?
    Illumina, Inc. - Common Stock has 19B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.